SL

Sheetal Luthra

Active Director Director DIN 06616224
DIN 06616224 First appointment Sep 2013 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2013
Shareholding value •••• Premium profile

About Sheetal Luthra

Data last updated:

Sheetal Luthra is a Director at Staymaxx Medical Private Limited (since 2013). The company operates in Healthcare. Staymaxx Medical Private Limited reported revenue of ₹1.20 Cr (FY 2025).

DIN 06616224
Primary Designation Director
Industry Healthcare
First Appointment 04 Sep 2013
Oldest Company Age 13 yrs
Largest company Staymaxx Medical Private Limited · ₹1.20 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Staymaxx Medical Private Limited U33110PB2013PTC037917
Director04 Sep 20132013₹1.20 Cr (FY 2025)Active

Board colleagues of Sheetal Luthra

Directorship timeline

Open interactive timeline →
Staymaxx Medical Private Limited
Premium access

Shareholding and investment profile for Sheetal Luthra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sheetal Luthra

Sheetal Luthra currently holds 1 directorship: Staymaxx Medical Private Limited (Director, since 04 Sep 2013, revenue ₹1.20 Cr (FY 2025)).

Sheetal Luthra was first appointed on 04 Sep 2013 as Director at Staymaxx Medical Private Limited.

The current boards of Sheetal Luthra's companies include Asha Rani (Staymaxx Medical Private Limited), Kumar Gaurav Luthra (Staymaxx Medical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available